Int. Journal of Drug R&D
USA Edition : EU Edition : PR Edition

Locum International Press.

Issues # 01 - 08
Eight issues per year

The International Journal of Drug R&D
Designed for pharmaceutical researchers in the NDA CMC (chemistry manufacture control) and Generic Drug Development sectors including detailed aspects of NDA/ANDA (bio/pivotal) and commercial validation batch manufacture. Reviews key CMC processes and structured drug design programs. Anticipate future harmonized drug design requirements. Dramatically improve your company's R&D new pipeline performance regardless of firm size.

Highlights new drug design requirement and how to use a development partner to speed product development and reduce risk. A forward looking peer reviewed journal that is relevant from the bench to the boardroom. Addresses the most up-to-date developments in CMC technology.

An essential first read for drug development chemists and scientists working in CMCs area of NDAs and ANDAs. An excellent source of know-how information on the nuts-and-bolts of drug development. Delivers authoritative perspective on the future of drug research and development.

Development know-how
Describes R&D approaches being adopted in a clear and user friendly way. Decision trees making R&D decisions analysis easier across the pipeline for increased productivity. Accelerated time-to-market programs.

Enhanced bottom-line performance with key know-how on CDER and OGDs expectations of the bio/pivotal batch manufacture highlighting side-by-side batch comparisons between bio/pivotal regulatory batch and commercial validation batches.

Full coverage
A comprehensive new forum filled with essential drug development data associated with CMC and on dosage form, preformulation techniques, scale-up, drug development, process development, dosage specific validation procedures, quality assurance and control.

Each issue targets a specific dosage form detailing developmental and scale-up topics. Each Journal issue contains material dedicated to the review of a specific dosage form and specific development and scale-up topics.

This Journal features drug development articles, technical reviews, procedural checklists, SOPs and Side-by-Side specification comparisons of all major dosage form parameters ranging from A (actives) to V (validation).

A primary source Journal to fill the ever changing information gap for CMC and Generic Drug Development. The Journal emphasizes a multidisciplinary approach between all key development and production departments.

80 - 95 pp illustrated b/w & color
Subscription - Print

$1499.00 - Print Edition (single-user airmail print edition worldwide)
$1699.00 - Corporate single license single pharma campus - (Print)
$1999.00 - Corporate multiple-user license - (Print edition maximizes distribution and readership for multiple pharma campus).

Online Members	DOWNLOAD from this JOURNAL	USA	Euro	Pacific
	The Journal Title and Cover Page >
Join IAGIM	The Journal's Annual Calendar >
	List of Worldwide Subscription Agents >